Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 11 of 11 entries
View as:

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04933968 Org: User:
Start: 03/21/22 End: 01/31/24 Due: 01/31/25

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04693637 Org: User:
Start: 01/15/21 End: 01/19/23 Due: 01/19/24

Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia

Phase: N/A Priority: Normal
NCT ID: NCT04605484 Org: User:
Start: 03/22/21 End: 10/20/22 Due: 10/20/23

Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)

Phase: N/A Priority: Normal
NCT ID: NCT02313857 Org: User:
Start: 09/30/15 End: 02/28/18 Due: 02/28/19

Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05179057 Org: User:
Start: 04/26/22 End: 01/31/24 Due: 01/31/25

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02108522 Org: User:
Start: 06/30/14 End: 12/31/19 Due: 12/31/20

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05305040 Org: User:
Start: 03/24/22 End: 01/30/24 Due: 01/30/25

Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)

Phase: N/A Priority: Normal
NCT ID: NCT02313844 Org: User:
Start: 03/01/18 End: 12/31/19 Due: 12/31/20

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Phase: N/A Priority: Normal
NCT ID: NCT02276820 Org: User:
Start: 12/07/17 End: 12/31/19 Due: 12/31/20

ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus

Phase: N/A Priority: Normal
NCT ID: NCT01570283 Org: User:
Start: 09/30/12 End: 09/30/17 Due: 09/30/18

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Phase: N/A Priority: Normal
NCT ID: NCT04390113 Org: User:
Start: 03/18/21 End: 01/30/24 Due: 01/30/25